Latest Strategy News

Askari Metals has successfully closed an oversubscribed rights issue raising approximately $1.6 million to accelerate exploration at its promising Nejo Gold and Copper Project in Ethiopia and the Uis Project in Namibia.

Dreadnought Resources has reported significant thick, near-surface gold intercepts from recent drilling at Cullen’s Find within its Mangaroon Gold Project, marking the first drilling there since 1986 and hinting at bulk gold deposit potential.

Belararox Ltd announces the immediate resignation of founding Managing Director Arvind Misra, with Chairman Neil Warburton stepping in as interim leader during the search for a new executive director.

Icetana reveals its FY26 strategy focused on transforming Security Operations Centers with predictive, explainable, and autonomous AI, aiming to enhance threat detection and operational efficiency.

Echo IQ has completed a pivotal clinical validation of its EchoSolv HF software at the Mayo Clinic, achieving outstanding accuracy ahead of its FDA submission. This milestone sets the stage for potential US market entry into a $60 billion heart failure diagnostics sector.

Black Cat Syndicate announces a leadership transition with James Bruce appointed as Managing Director from April 2026, succeeding founder Gareth Solly who will remain as a Non-Executive Director.

Somerset Minerals confirms robust high-grade copper mineralisation at its Jura North prospect within the Coppermine Project, Nunavut, with plans for an aggressive 2026 drilling campaign and regional exploration across its extensive landholding.

Prodigy Gold reports strong gold intercepts from its 2025 drilling at the Tregony Deposit, setting the stage for an updated resource estimate and potential expansion in 2026.

PYC Therapeutics has secured Safety Review Committee approval to escalate dosing in its clinical trial for PYC-003, an RNA therapy targeting Polycystic Kidney Disease. This milestone moves the drug closer to pivotal Phase 2/3 trials.

Aeris Resources reported solid FY25 results within guidance and secured $80 million in new equity to fund exploration and development projects, positioning itself for significant growth in FY26.

Ryman Healthcare has completed a full refinancing of its $2 billion syndicated loan facilities, extending the average maturity to five years and enhancing funding flexibility. The move aligns with the company’s disciplined growth strategy and sets the stage for future capital management decisions.

The a2 Milk Company has secured key regulatory approvals in China, moving closer to launching its infant formula products under the a2MC brand by mid-2027.